Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

Patients who received the original monovalent mRNA COVID-19 vaccine were less likely than unvaccinated patients to be hospitalized for COVID-19-associated VTE.

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

The covid wave this winter is less severe compared with previous years, with hospitalization rates down and wastewater levels lower.

Hospitalizations and general "syndromic" cases were at 10+ statewide for the week. The number of reported COVID cases ...

This winter season more cases of flu have taken over the United States of America with decreasing reports of Coronavirus.

The mRNA-1273.815 vaccine provided significant protection against COVID-19-related hospitalizations and medically attended COVID-19 among US adults.

Long-term nursing home stays and deaths after hospitalization for sepsis went up during the COVID-19 pandemic compared with before it, a new study finds.

A large study of Veterans Affairs (VA) patients in JAMA Internal Medicine shows that, during the 2022 to 2023 season, having ...

Paxlovid use was associated with lower rates of hospitalization and death, particularly among older adults, a new study finds ...